Oxygenta Pharmaceutical informs about disclosure

18 Apr 2024 Evaluate
Oxygenta Pharmaceutical has informed that it enclosed a copy of Detailed Public Statement under Regulations 13(4), 14(3) and 15(2) of The Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended for the attention of the eligible Equity Shareholders of Oxygenta Pharmaceutical (Target Company).

The above information is a part of company’s filings submitted to BSE.

Oxygenta Pharma Share Price

50.12 -1.93 (-3.71%)
11-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1824.90
Dr. Reddys Lab 1325.50
Cipla 1329.90
Zydus Lifesciences 922.00
Lupin 2345.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×